| Date Filed | Type | Description |
| 08/07/2023 |
4
| Lindborg Stacy (Co-CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Lindborg Stacy (Director) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 2,000 options to buy
@ $0 |
|
| 01/04/2023 |
4
| Lindborg Stacy (Co-CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Lindborg Stacy (Director) has filed a Form 4 on Celsion CORP|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 06/08/2021 |
3
| Lindborg Stacy (Director) has filed a Form 3 on Celsion CORP |
| 11/19/2020 |
4
| Lindborg Stacy (EVP, Head Global Clin Research) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Bought 200 options to buy
@ $10, valued at
$2k
|
|
| 06/01/2020 |
4
| Lindborg Stacy (EVP, Head Global Clin Research) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 25,000 shares
@ $0
Granted 100,000 options to buy
@ $7.67, valued at
$767k
|
|
| 06/01/2020 |
3
| Lindborg Stacy (EVP, Head Global Clin Research) has filed a Form 3 on BRAINSTORM CELL THERAPEUTICS INC. |